LEADER 02815nam 22006014a 450 001 9910450190803321 005 20200520144314.0 010 $a92-808-7091-2 010 $a1-4237-6606-7 035 $a(CKB)1000000000246804 035 $a(EBL)829913 035 $a(OCoLC)826486220 035 $a(SSID)ssj0000234953 035 $a(PQKBManifestationID)11201071 035 $a(PQKBTitleCode)TC0000234953 035 $a(PQKBWorkID)10241939 035 $a(PQKB)11387717 035 $a(MiAaPQ)EBC829913 035 $a(Au-PeEL)EBL829913 035 $a(CaPaEBR)ebr10120740 035 $a(EXLCZ)991000000000246804 100 $a20050419d2005 uf 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aRegulating bioprospecting$b[electronic resource] $einstitutions for drug research, access, and benefit-sharing /$fPadmashree Gehl Sampath 210 $aTokyo ;$aNew York $cUnited Nations University Press$d2005 215 $a1 online resource (288 p.) 300 $aDescription based upon print version of record. 311 $a92-808-1112-6 320 $aIncludes bibliographical references (p. 251-267) and index. 327 $aBioprospecting for drug research : an overview -- Drug R&D and the structure of the industry -- International policy dimensions of bioprospecting -- Transaction costs and their impact on the market for bioprospecting -- Intellectual property rights on traditional medicinal knowledge : a process oriented perspective -- The scope of the right to regulate access. 330 $aBioprospecting, or the search for useful biochemical compounds and genes in nature, has been the focus of international negotiations for more than a decade, yet the debate on the terms for access to genetic resources, traditional knowledge and benefit-sharing is far from settled.This book examines the optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research. Focusing on the economics of contracts, it shows that the rights exchanged are complementary at each stage of drug discovery and the development of genetic resources.Defining and enfor 606 $aDrugs$vPatents 606 $aGenes$vPatents 606 $aDrugs$xTesting$xLaw and legislation 606 $aGenetic engineering$xLaw and legislation 608 $aElectronic books. 615 0$aDrugs 615 0$aGenes 615 0$aDrugs$xTesting$xLaw and legislation. 615 0$aGenetic engineering$xLaw and legislation. 676 $a344.04/233 700 $aSampath$b Padmashree Gehl$0864097 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910450190803321 996 $aRegulating bioprospecting$91928743 997 $aUNINA